Frontlight ResearchEarly access
Trial site
Interventional Cardiology Medical Group
- 10running trials
- 1closed trial
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation3 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Heart failure2 trials
- Obesity2 trials
- Peripheral artery disease2 trials
- Chronic kidney disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Familial hypercholesterolaemia1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Recruiting8 trials
- Active, not recruiting1 trial
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Regeneron Pharmaceuticals4 trials
- Boehringer Ingelheim3 trials
- Amgen1 trial
- Duke University1 trial
- Eli Lilly and Company1 trial
- and 1 more
Running trials
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation3 recruiting
- Stroke3 recruiting
- Coronary artery disease2 recruiting
- Obesity2 recruiting
- Peripheral artery disease2 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026